Late-stage preclinical development of teixobactin to treat drug-resistant infections

Active Project Grant Awarded Last action

Award ID
HT94252310376
Recipient
Awarding agency
Obligated
$4,499,475

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 88% complete
Originally
Place of performance
Cambridge, MA 02138, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Original award $4,499,475

Quick answers

Who received award HT94252310376?

HT94252310376 was awarded to Novobiotic Pharmaceuticals, LLC by Defense Health Agency (Department of Defense) on May 1, 2023.

How much is award HT94252310376 worth?

$4,499,475 has been obligated on HT94252310376.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award